Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Hospitals and pharmacies debate 340B reporting amendments; committee delays HB1473
Summary
Stakeholders and lawmakers debated proposed reporting requirements tied to HB1473 and the 340B program; hospitals urged narrower reporting, while advocates for reporting sought data on program use. Committee deferred action to a later session.
Stakeholders and lawmakers debated revisions to House Bill 1473, a measure tied to the federal 340B drug-pricing program and the use of contract pharmacies, but the House Committee on Industry, Business and Labor did not take final action and deferred further consideration.
Tim Blazell of the North Dakota Hospital Association and Andy Askew, vice president of public policy at Accenture Health, told the committee 340B is essential to keeping services open in rural communities. “This is a really important program for not just Accenture Health, but rural hospitals across North Dakota,” Askew said, noting Accenture Health operates 14 hospitals across Minnesota, North Dakota and Wisconsin and that critical access hospitals rely on contract…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
